A pH-responsive bi-MIL-88B MOF coated with folic acid-conjugated chitosan as a promising nanocarrier for targeted drug delivery of 5-Fluorouracil
Frontiers in Pharmacology · 06.09.2023 · 14
DOI: 10.3389/fphar.2023.1265440 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 06.09.2023. Verfasst von Muhammad Usman Akbar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Gomal Center of Biochemistry and Biotechnology, Gomal University, Dera Ismail Khan, Pakistan. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer has remained one of the leading causes of death worldwide, with a lack of effective treatment. The intrinsic shortcomings of conventional therapeutics regarding tumor specificity and non-specific toxicity prompt us to look for alternative therapeutics to mitigate these limitations. In this regard, we developed multifunctional bimetallic (FeCo) bi-MIL-88B-FC MOFs modified with folic acid—conjugated chitosan (FC) as drug delivery systems (DDS) for targeted delivery of 5-Fluorouracil (5-FU). The bi-MIL-88B nanocarriers were characterized through various techniques, including powder X-ray diffraction, scanning electron microscopy, energy-dispersive X-ray, thermogravimetric analysis, and Fourier transform infrared spectroscopy. Interestingly, 5-FU@bi-MIL-88B-FC showed slower release of 5-FU due to a gated effect phenomenon endowed by FC surface coating compared to un-modified 5-FU@bi-MIL-88B. The pH-responsive drug release was observed, with 58% of the loaded 5-FU released in cancer cells mimicking pH (5.2) compared to only 24.9% released under physiological pH (5.4). The in vitro cytotoxicity and cellular internalization experiments revealed the superiority of 5-FU@bi-MIL-88B-FC as a highly potent targeted DDS against folate receptor (FR) positive SW480 cancer cells. Moreover, due to the presence of Fe and Co in the structure, bi-MIL-88B exhibited peroxidase-like activity for chemodynamic therapy. Based on the results, 5-FU@bi-MIL-88B-FC could serve as promising candidate for smart DDS by sustained drug release and selective targeting.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gomal Center of Biochemistry and Biotechnology, Gomal University, Dera Ismail Khan, Pakistan.
- Henan International Joint Laboratory of Nuclear Protein Regulation, School of Basic Medical Sciences, Henan University, Kaifeng, China.
- Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan.
- Department of Preventive Medicine, Institute of Bioinformatics, Henan Provincial Engineering Center for Tumor Molecular Medicine, School of Basic Medical Sciences, Henan University, Kaifeng, China.
- Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
- Department of Chemistry and Chemical Engineering, Syed Babar Ali School of Science and Engineering, Lahore University of Management Sciences (LUMS), Lahore, Pakistan.
Zitieren
APA
Akbar, M. U., Khattak, S., Khan, M. I., Saddozai, U. A. K., Ali, N., AlAsmari, A. F., Zaheer, M., & Badar, M. (2023). A pH-responsive bi-MIL-88B MOF coated with folic acid-conjugated chitosan as a promising nanocarrier for targeted drug delivery of 5-Fluorouracil. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1265440
Vancouver
Akbar MU, Khattak S, Khan MI, Saddozai UAK, Ali N, AlAsmari AF, et al. A pH-responsive bi-MIL-88B MOF coated with folic acid-conjugated chitosan as a promising nanocarrier for targeted drug delivery of 5-Fluorouracil. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1265440
BibTeX
@article{Akbar2023,
author = {Akbar, Muhammad Usman and Khattak, Saadullah and Khan, Malik Ihsanullah and Saddozai, Umair Ali Khan and Ali, Nemat and AlAsmari, Abdullah F and Zaheer, Muhammad and Badar, Muhammad},
title = {A pH-responsive bi-MIL-88B MOF coated with folic acid-conjugated chitosan as a promising nanocarrier for targeted drug delivery of 5-Fluorouracil},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1265440}
}
EUVIMED